ArticleFrontiers in pediatrics2026
Italian multidisciplinary delphi consensus on home management of nausea and vomiting in children with acute gastroenteritis (NoEmesi Project).
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Vomiting in pediatric acute gastroenteritis (AGE) is a major driver of distress, caregiver anxiety, and failure of oral rehydration, while guidance for home management and pediatric antiemetic use is limited and influenced by regulatory restrictions. Methods: We conducted a modified Delphi consensus in three phases (statement development after literature review, anonymous online rating, and final refinement) involving a national multidisciplinary panel of 70 Italian pediatricians. Results: Twenty-one statements addressing clinical aspects of vomiting in AGE and the pharmacology, safety, and use of commonly prescribed antiemetics (with emphasis on metoclopramide) were rated on a five-point Likert scale; consensus was predefined as ≥80% ratings of 4-5. All 21 statements met the consensus threshold (agreement 83%-100%; mean scores 4.2-4.9). The highest agreement concerned the clinical burden of vomiting in AGE, key mechanistic pathways, and practical safety considerations for metoclopramide (including dosing limits, age-related caution, and caregiver counseling). The panel agreed that, in selected children with persistent vomiting preventing oral rehydration, cautious antiemetic use, particularly metoclopramide, may support home management when safety precautions are followed, off-label requirements are respected, and parents are adequately counseled. Discussion: This Delphi consensus provides pragmatic, expert-endorsed recommendations for home management of nausea and vomiting in pediatric AGE. Oral rehydration solutions (ORS) remain the cornerstone of care; metoclopramide may be considered in carefully selected cases to quickly resolve symptoms, facilitate rehydration and reduce dehydration risk, provided that clinicians adopt strict risk-benefit assessment and good clinical practice safeguards.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.